XIE Lin, GAO Hui-bing. The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
|
Citation:
|
XIE Lin, GAO Hui-bing. The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
|
XIE Lin, GAO Hui-bing. The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
|
Citation:
|
XIE Lin, GAO Hui-bing. The Efficacy and Safety of Pembrolizumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 213-216. DOI: 10.12019/j.issn.1671-5144.2020.04.004
|
DownLoad: